New! Sign up for our free email newsletter.
Science News
from research organizations

Nonalcoholic fatty liver disease progression

New study shows role of adenosine kinase in fat deposition, liver inflammation

October 5, 2022
Texas A&M AgriLife Communications
A study provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD.

A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease, NAFLD.

The study, "Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation," appeared in September in the scientific journal Gastroenterology.

Hepatocytes are cells that play pivotal roles in liver function, including in metabolism, detoxification, protein synthesis and innate immunity.

An important player in the proper function of hepatocytes is an enzyme called adenosine kinase, ADK. However, the current study shows that ADK can also drive liver disease progression.

"We aimed to study whether hepatocyte ADK functions to promote excessive fat deposition and liver inflammation," said Chaodong Wu, M.D., Ph.D., an AgriLife Research Faculty Fellow in the Texas A&M Department of Nutrition. Wu is also a Presidential Impact Fellow of Texas A&M University and the corresponding author for the study.

Wu said NAFLD is highly associated with obesity and progresses to an advanced stage when the liver develops overt inflammatory damage.

This study pointed to the idea that hepatocyte ADK may be an important therapeutic target for managing obesity and NAFLD.

"The research demonstrated that hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation and is a key factor in the pathogenesis of nonalcoholic fatty liver disease," he said. "There is already some evidence as to how making dietary changes can be effective in helping prevent or reduce the severity of NAFLD. If further research validates the effects of dietary components on inhibiting adenosine kinase in hepatocytes, scientists could develop new approaches for managing this disease.

About the study

The researchers examined how changes in ADK activity relate to levels of liver inflammation and amount of fat in the liver. The team studied mice that were genetically engineered to have either more or less ADK activity than normal.

The team fed the mice a high-fat diet for 12 weeks or a methionine-choline deficient diet, which is known to contribute to liver injury, for five weeks.

Under these diets, mice with lowered ADK activity in their hepatocytes had lower levels of fat and inflammation in the liver than controls. In contrast, mice with elevated ADK activity had greater body weight and increased body fat, liver fat and liver inflammation levels than normal mice.

Going further, the team conducted experiments to clarify exactly how ADK activity causes these effects.

Wu said the study included the analysis of cell-to-cell crosstalk using single-cell RNA sequencing, which was done with assistance from James Cai, Ph.D., a researcher in Texas A&M's Department of Veterinary Integrative Biosciences.

"The study's analysis of lipid profiles in mouse liver samples indicated increased presence of lipids that promote mitochondrial dysfunction, leading in turn to liver inflammation," Wu said.

The team went on to analyze ADK activity and liver health in human liver samples. Like in mice, the data showed that decreased levels of ADK correlated with lower levels of NAFLD, while increased levels of the enzyme were linked to exacerbated liver steatosis and inflammation. The results also showed that ADK promotes excessive fat deposition and liver inflammation through suppressing fatty acid oxidation in liver cells.

"The amount of hepatocyte ADK protein was positively correlated with the degrees of hepatic steatosis in livers from human subjects," Wu said. "This novel finding highlights the enzyme's pathological importance in human NAFLD."

Diet and NAFLD

A 2020 study by Chaidong Wu, Ph.D., and his team showed that indole, a natural compound found in cruciferous vegetables, may be effective against nonalcoholic fatty liver disease. (Photo courtesy of Texas A&M Department of Horticultural Sciences)

Wu said the new study strongly indicates that an unhealthy diet, such as a diet with enriched saturated fatty acids, has a stimulatory effect on increasing the adenosine kinase protein amount in the liver.

"This, in turn, positively correlates with the degrees of obesity, NAFLD and systemic insulin resistance," he said.

Wu previously investigated the role of diet in NAFLD in a 2020 study led by AgriLife Research scientists. The study, published in Hepatology, showed that indole -- a natural compound found in gut bacteria and cruciferous vegetables such as cabbage, kale, cauliflower and Brussels sprouts -- may be effective in fighting the disease.

"This natural compound may lead to new treatments or preventive measures for NAFLD," Wu said. "Healthy foods with high capacity for indole production are important in preventing NAFLD and are beneficial for improving the health of those with it."

He said preventing NAFLD's development and progression may depend on nutritional approaches to ensure that gut microbes allow indole and other metabolites to function effectively.

Story Source:

Materials provided by Texas A&M AgriLife Communications. Original written by Paul Schattenberg. Note: Content may be edited for style and length.

Journal Reference:

  1. Honggui Li, Juan Zheng, Qian Xu, Yongjian Yang, Jing Zhou, Xinlei Guo, Yongfeng Cai, James J. Cai, Linglin Xie, Joseph Awika, Xianlin Han, Qingsheng Li, Lindsey Kennedy, Heather Francis, Shannon Glaser, Yuqing Huo, Gianfranco Alpini, Chaodong Wu. Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation. Gastroenterology, 2022; DOI: 10.1053/j.gastro.2022.09.027

Cite This Page:

Texas A&M AgriLife Communications. "Nonalcoholic fatty liver disease progression." ScienceDaily. ScienceDaily, 5 October 2022. <>.
Texas A&M AgriLife Communications. (2022, October 5). Nonalcoholic fatty liver disease progression. ScienceDaily. Retrieved December 5, 2023 from
Texas A&M AgriLife Communications. "Nonalcoholic fatty liver disease progression." ScienceDaily. (accessed December 5, 2023).

Explore More
from ScienceDaily